Drug Policy Modelling Program (DPMP)

image - DPMP Logo FINAL
The Drug Policy Modelling Program (DPMP) aims to improve Australian drug policy. The goal of the DPMP is to create valuable new drug policy insights, ideas and interventions that will allow Australia to respond with alacrity and success to drug-related problems. We do this through generating new research evidence which is timely and relevant to current drug policy issues; translating research findings into meaningful information to assist policy decision-makers, and studying policy processes.
About the Program: 

The DPMP, funded through a core grant from the Colonial Foundation Trust, is a collaboration between the National Drug and Alcohol Research Centre (which houses the central team) and a number of research institutions including amongst others The Burnet Institute, University of Queensland, the National Drug Research Institute and Turning Point Alcohol and Drug Centre.

The DPMP is a multi-disciplinary team with psychology, health economics, criminology, public policy, sociology and economics all represented. Our work concerns all aspects of drug policy, and covers the four pillars of drug policy: law enforcement, prevention, treatment and harm reduction.

DPMP has three streams of activity:

·       Generating new research evidence;

·       Providing tools for policy makers to use evidence; and

·       Studying policy-making processes in Australia.

Below is a selection of output produced by DPMP. The full list of DPMP projects and publications can be found at the DPMP website.

Other Members: 
The full list of DPMP team members and collaborators can be found at the DPMP website: http://www.dpmp.unsw.edu.au/

People related to this Program

Projects related to this Program

image - Cocaine Pile 280
Project Contacts: Dr Jenny Chalmers

Publications related to this Program

  • Hughes, C.E., Bright, D.A., & Chalmers, J., (2016, early online view). Social network analysis of Australian poly-drug trafficking networks: How do drug traffickers manage multiple illicit drugs? Social Networks. http://dx.doi.org/10.1016/j.socnet.2016.11.004

  • King T; Ritter A; Hamilton M, 2013, 'Setting the scene', in Ritter A; King T; Hamilton M (ed.), Drug Use in Australian Society, edn. 1, Oxford University Press, Australia, pp. 3 - 26, http://www.oup.com.au/titles/higher_ed/health_sciences/9780195518863

  • Ritter A; Lancaster K, 2013, 'Policy models and influences on policy processes', in Ritter A; King T; Hamilton M (ed.), Drug Use in Australian Society, edn. 1, Oxford University Press, Australia, pp. 99 - 132, http://www.oup.com.au/titles/higher_ed/health_sciences/9780195518863

  • Hughes CE, 2013, 'Drugs and Culture: Knowledge, Consumption and Policy: [book review]', Drug and Alcohol Review, vol. 32, pp. 336 - 337, 10.1111/dar.12007/full

  • Lancaster K; Ritter A; Stafford J, 2013, 'Public opinion and drug policy in Australia: Engaging the ‘affected community’', Drug and Alcohol Review, vol. 32, pp. 60 - 66, 10.1111/j.1465-3362.2012.00497.x/pdf

  • Frewen A; Molan J; Ritter A; Bell J, 2012, 'A new approach to developing clinically-based guidelines: the experience of developing guidelines for management of drug dependent women and neonates and for cannabis dependence', International Journal of Person-Centered Medicine, vol. 2, pp. 870 - 877, http://www.ijpcm.org/index.php/IJPCM/article/view/300

  • Ritter A, 2012, 'Alison Ritter on Friedman et al.'s "has United States drug policy failed? and how could we know?" policy as structured interaction, engaging multiple voices', Substance Use and Misuse, vol. 47, pp. 1406 - 1407, 10.3109/10826084.2012.723555

  • Hughes CE; Wodak AD, 2012, 'Addressing the question: "What can Australia learn from different approaches to drugs in Europe including especially Portugal, Switzerland, the Netherlands and Sweden?”', in Addressing the question: "What can Australia learn from different approaches to drugs in Europe including especially Portugal, Switzerland, the Netherlands and Sweden?”, Australia21, Melbourne, pp. 1 - 21, presented at Australia21 Roundtable, Melbourne, 06 July 2012, http://ndarc.med.unsw.edu.au/sites/ndarc.cms.med.unsw.edu.au/files/ndarc/resources/Australia21%20background%20paper%20July%202012.pdf

  • Ritter A, 2011, 'The role of research evidence in drug policy development in Australia', Politicka misao, vol. 48, pp. 141-156, http://hrcak.srce.hr/index.php?show=clanak&id_clanak_jezik=119724

  • Carragher N; Chalmers JJ, 2011, What are the options? Pricing and taxation policy reforms to redress excessive alcohol consumption and related harms in Australia, NSW Bureau of Crime Statistics and Research, Sydney, NSW

  • Hughes CE; Stevens A, 2012, 'A resounding success or a disastrous failure: Re-examining the interpretation of evidence on the Portuguese decriminalisation of illicit drugs', Drug and Alcohol Review, vol. 31, pp. 101 - 113, 10.1111/j.1465-3362.2011.00383.x/pdf

  • Ritter A; Matthew-Simmons F; Carragher N, 2012, 'Why the alcohol and other drug community should support gay marriage: Editorial', Drug and Alcohol Review, vol. 31, pp. 1 - 3, 10.1111/j.1465-3362.2011.00410.x/pdf

  • Hughes C; Spicer B; Lancaster K, 2011, 'Young people's perceptions of and engagement with news media reporting on illicit drug issues: An Australian study', Current Issues in Criminal Justice, vol. 23, pp. 145 - 161

  • Hughes CE; Chalmers JJ; Bright DA; Matthew-Simmons F; Sindicich N, 2012, 'Examining supply changes in Australia's cocaine market', Drug and Alcohol Review, vol. 31, pp. 263 - 272, 10.1111/j.1465-3362.2011.00350.x/full

  • Hughes CE; Lancaster K; Spicer B, 2011, 'How do Australian news media depict illicit drug issues? An analysis of print media reporting across and between illicit drugs, 2003-2008', International Journal of Drug Policy, vol. 22, pp. 285 - 291, 10.1016/j.drugpo.2011.05.008

  • Ritter A, 2011, 'Ensuring the policy relevance of population health research: experiences from the Drug Policy Modelling Program.', New South Wales public health bulletin, vol. 22, pp. 19 - 22

  • Bright DA; Ritter A, 2011, 'Australian trends in drug user and drug dealer arrest rates: 1993 to 2006-07', Psychiatry, Psychology and Law, vol. 18, pp. 190 - 201, 10.1080/13218711003739524

  • Walker BD, 1999, Exhibited: 4 ways` quadrivium at , 01 January 1999, publication category:

  • Eppens MC; Craig ME; Jones TW; Silink M; Ong S; Ping YJ, 2006, 'Type 2 diabetes in youth from the Western Pacific region: Glycaemic control, diabetes care and complications', Current Medical Research and Opinion, vol. 22, no. 5, pp. 1013 - 1020, http://dx.doi.org/10.1185/030079906X104795

  • Adie S; Yip C; Chu F; Morris DL, 2009, 'Resection of liver metastases from colorectal cancer: does preoperative chemotherapy affect the accuracy of PET in preoperative planning?', ANZ J Surg, vol. 79, pp. 358 - 361, 10.1111/j.1445-2197.2009.04889.x

  • Chalmers JJ; Ritter A; Heffernan M; McDonnell GD, 2009, Modelling pharmacotherapy maintenance in Australia: Exploring affordability, availability, accessibility and quality using system dynamics., 1, Australian National Council on Drugs, Canberra

  • Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A, 2006, 'Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load', Journal of Infectious Diseases, vol. 193, pp. 664 - 671, 10.1086/500248

  • Walsh WF; Morris P; Morgan P; Harris ML; Parker GB, 2000, 'The Importance of a Functioning PCL when using an Anterior-Posterior Gliding, Rotating Platform Total Knee Prostheses (AP-Glide).', in American Academy of Orthopaedic Surgeons. 67th Annual Meeting, American Academy of Orthopaedic Surgeons. 67th Annual Meeting, Orlando, Florida, USA, pp. 584, presented at American Academy of Orthopaedic Surgeons. 67th Annual Meeting, Orlando, Florida, USA, 15 - 19 March 2000

  • Bye AM; Flanagan D, 1995, 'Electroencephalograms clinical observations and the monitoring of neonatal seizures', Journal of Paediatrics and Child Health (Vol. 48, Suppl. 2, 2012, 1–13), pp. 503 - 507

  • Guillemin GJ; Brew BJ; Noonan CE; Knight TG; Smythe GA; Cullen KM, 2007, 'Mass spectrometric detection of quinolinic acid in microdissected Alzheimer's disease plaques', International Congress Series, vol. 1304, pp. 404 - 408, 10.1016/j.ics.2007.07.012

  • Walker K; Donoghue J; Mitten-Lewis S, 2007, 'Measuring the impact of a team model of nursing practice using work sampling', Australian Health Review, vol. 31, pp. 98 - 107

  • Mansfield KJ; Chandran JJ; Vaux KJ; Millard RJ; Christopoulos A; Mitchelson FJ; Burcher E, 2009, 'Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa', Journal of Pharmacology and Experimental Therapeutics, vol. 328, pp. 893 - 899, 10.1124/jpet.108.145508

  • Hernández-Guerrero M; Davis TP; Barner-Kowollik C; Stenzel MH, 2005, 'Polystyrene comb polymers built on cellulose or poly(styrene-co-2-hydroxyethylmethacrylate) backbones as substrates for the preparation of structured honeycomb films', European Polymer Journal, vol. 41, pp. 2264 - 2277, 10.1016/j.eurpolymj.2005.04.040

  • Koh JL; Yan TD; Glenn D; Morris DL, 2009, 'Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis', Annals of Surgical Oncology, vol. 16, pp. 327 - 333, 10.1245/s10434-008-0234-2

Resources related to this Group

DPMP Bulletins, Working papers/discussion papers

DPMP Monographs

DPMP Bulletins